Itron director granted 232-share stock award
LEYDEN TIMOTHY M reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LEYDEN TIMOTHY M reported acquisition or exercise transactions in this Form 4 filing.
Itron, Inc. director Timothy M. Leyden received a grant of 232 shares of common stock as part of the quarterly compensation that independent board members receive. The award was at no cash cost per share and increased his direct holdings to 16,005 shares.
According to the disclosure, Leyden deferred receipt of 87 of these shares under Itron's Executive Deferred Compensation Plan, so only part of the award was taken immediately in stock while the remainder was deferred.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 232 | $0.00 | $0.00 |
Footnotes (1)
- F1. Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Mr. Leyden deferred receipt of 87 shares pursuant to Itron's Executive Deferred Compensation Plan.
Key Figures
Key Terms
Grant, award, or other acquisition financial
Executive Deferred Compensation Plan financial
independent members of Itron's board of directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Itron (ITRI) disclose for Timothy M. Leyden?
Is Timothy M. Leyden’s Itron (ITRI) Form 4 transaction a purchase or a grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.